Cephalexin compared to ampicillin treatment of otitis media. 1976

B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin

Cephalexin was compared to ampicillin for the treatment of otitis media in a randomized study. Bacteriologic diagnosis was sought by needle tympanocentesis in 179 children. No overall statistically significant differences were noted between the two groups; however, 20 patients who received cephalexin had a poor response to therapy whereas only five recipients of ampicillin responded poorly. A significant difference (P less than .05) between the two regimens was noted when Hemophilus influenzae was recovered. Fifty per cent of the children with H. influenzae otitis media who were treated with cephalexin responded poorly; no patients receiving ampicillin had a poor response. Our data suggest that the use of cephalexin monohydrate is not warranted for treatment of otitis media due to H. influenzae even when the isolate proves sensitive to this drug in vitro. In selected patients with otitis media caused by Staphylococcus aureus which is resistant to penicillin, cephalexin may provide effective treatment.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010033 Otitis Media Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. Middle Ear Inflammation,Inflammation, Middle Ear
D002506 Cephalexin A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms. 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,Cefalexin,Cephalexin Dihydride,Cephalexin Hemihydrate,Cephalexin Hydrochloride,Cephalexin Monohydrate,Cephalexin Monohydrochloride,Cephalexin Monohydrochloride, Monohydrate,Cephalexin, (6R-(6alpha,7alpha(R*)))-Isomer,Cephalexin, (6R-(6alpha,7beta(S*)))-Isomer,Cephalexin, (6R-(6alpha,7beta))-Isomer,Cephalexin, Monosodium Salt,Cephalexin, Monosodium Salt, (6R-(6alpha,7beta))-Isomer,Ceporexine,Palitrex
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae

Related Publications

B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
January 1978, Pediatrics,
B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
November 1967, JAMA,
B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
October 1975, JAMA,
B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
June 1980, The Journal of pediatrics,
B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
January 1974, Current medical research and opinion,
B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
August 1983, Archives of otolaryngology (Chicago, Ill. : 1960),
B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
June 1974, The Journal of infectious diseases,
B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
October 1995, International journal of pediatric otorhinolaryngology,
B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
March 1984, Ear, nose, & throat journal,
B W Stechenberg, and D Anderson, and M J Chang, and L Dunkle, and M Wong, and D Van Reken, and L K Pickering, and R D Feigin
December 1974, Lancet (London, England),
Copied contents to your clipboard!